Page last updated: 2024-09-03

rufinamide and Aging

rufinamide has been researched along with Aging in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, JH; Chen, BH; Hwang, IK; Kang, IJ; Kim, DW; Kim, H; Kim, YM; Lee, CH; Lee, JC; Lee, TK; Park, JH; Song, M; Won, MH; Yan, BC	1

Other Studies

1 other study(ies) available for rufinamide and Aging

Article	Year
Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB. Chemico-biological interactions, 2018, Apr-25, Volume: 286 Topics: Aging; Animals; Anticonvulsants; Body Weight; Brain-Derived Neurotrophic Factor; Cognition; CREB-Binding Protein; Dentate Gyrus; Gene Expression Regulation; Gerbillinae; Insulin-Like Growth Factor I; Ki-67 Antigen; Male; Microscopy, Fluorescence; Neurogenesis; Receptor, IGF Type 1; Receptor, trkB; Triazoles	2018

Article

Year

Rufinamide, an antiepileptic drug, improves cognition and increases neurogenesis in the aged gerbil hippocampal dentate gyrus via increasing expressions of IGF-1, IGF-1R and p-CREB.

Chemico-biological interactions, 2018, Apr-25, Volume: 286

Topics: Aging; Animals; Anticonvulsants; Body Weight; Brain-Derived Neurotrophic Factor; Cognition; CREB-Binding Protein; Dentate Gyrus; Gene Expression Regulation; Gerbillinae; Insulin-Like Growth Factor I; Ki-67 Antigen; Male; Microscopy, Fluorescence; Neurogenesis; Receptor, IGF Type 1; Receptor, trkB; Triazoles

2018